Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-Term Safety Study of OZURDEX® in Clinical Practice

NCT01539577 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT01539577
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01539577 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-Term Safety Study of OZURDEX® in Clinical Practice
Lead sponsor
Allergan
Phase
Observational
Overall status
Completed
Start date
March 31, 2012
Completion date
March 31, 2016
Enrollment
875 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

macular edema, retinal vein occlusion, uveitis, posterior